Our API development and manufacturing services support drug substances that require advanced synthesis expertise, process development and scalable solutions for small molecule drug development.
We offer a tailored approach with the right science upfront leveraging drug substance sparing methodologies to maximize insight while minimizing API use—to provide rapid and reliable advancement of low solubility compounds through our bioavailability enhancement capabilities (BAE).
We focus on specialty and enhanced drug products with premier capabilities in bioavailability enhancement and low dose/highly potent applications.
As a CDMO with over a century of expertise, we specialize in a range of services, from drug development to manufacturing.
From drug substance to drug product. From feasibility to clinical trials to commercial supply. We are an industry-leading small molecules CDMO providing integrated support across development and manufacturing. With our world-class, global, high-quality facilities, we investigate innovative ways to bring your molecule to life.
Your molecule is our number one priority.
Sign up. Stay up-to-date.